Research Interest

  • Molecular Mechanism of interleukin-33(IL-33) in systemic lupus erythematosus
  • Non-uric acid risk factors in the pathogenesis of gouty arthritis
  • The role of DKK-1 in the bone destruction of rheumatoid arthritis


Featured Publications LegendFeatured Publications

Elevated serum interleukin-35 is associated with disease activity in patients with systemic lupus erythematosus.
Li C, Liu N, Zhu H, Xu L, Mu R Int J Rheum Dis 2017 Jul
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C, Wang XR, Ji HJ, Zhang XY, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu JT, Liu XY, Sun L, Chen HY, Wei P, Wang JX, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai B, Li XF, Song LJ, Wang Y, Wang XY, Tang YD, Su Y, Mu R, Li ZG Clin. Rheumatol. 2017 Mar
Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG Clin. Rheumatol. 2017 Jan
Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study.
Zhang XW, Li C, Ma XX, Zhao JX, An Y, Liu S, Li Y, Li ZG Clin. Rheumatol. 2014 Apr
Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis.
Li C, Mu R, Guo J, Wu X, Tu X, Liu X, Hu F, Guo S, Zhu J, Xu H, Li Z Arthritis Res. Ther. 2014 Apr 16 2 R105
Antilymphocyte antibodies in systemic lupus erythematosus: association with disease activity and lymphopenia.
Li C, Mu R, Lu XY, He J, Jia RL, Li ZG, J Immunol Res 2014 2014 672126
National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China.
Mu R, Li C, Zhu JX, Zhang XY, Duan TJ, Feng M, Wang GC, Zhang FC, Li ZG, Int J Rheum Dis 2013 Jun 16 3 258-63